Skip to main content

Table 6 Subgroup analysis of changes in fibrosis scores

From: Evaluation of long-term changes of aspartate—platelet ratio index, FIB4, and liver stiffness in chronic hepatitis C patients successfully treated by direct-acting antivirals

Baseline TE LSM APRI FIB4
Baseline Follow-up P value Baseline Follow-up P value Baseline Follow-up P value
F0 4.34±0.7 5.05±2.4 0.19 0.46±0.34 0.24±0.13 0.004 1±0.6 0.9±0.6 0.5
F1 6 ± 0.4 5 ± 1.2 <0.001 0.4±0.3 0.26±0.1 0.006 1.1±0.8 0.98±0.5 0.37
F2 8.1±0.8 6.9±3 0.15 0.48±0.2 0.2±0.1 0.001 1.15±0.5 0.95±0.5 0.13
F3 11±0.8 8.5±2 0.02 0.78±0.7 0.3±0.1 0.06 1.47±0.8 0.95±0.4 0.08
F4 21±8.6 18.5±7.5 0.14 0.86±0.5 0.4±0.25 <0.001 3.3±2.5 2±1.5 0.01